Sales Already Growing As Vascepa Secures Cardio Approval

Fish Oil Derivative Seen As Biggest Advance In Decades

 
• By Andrew McConaghie

Company forecasts 2020 sales as high as $700m after regulator grants broad label.

FDASignBldg21Entrance_1200x675
The FDA's decision came more than two weeks early

More from New Products

More from Scrip